The Peptide Boom: Josh Felber on GLP-1 Muscle Loss, Recovery and Longevity

Entrepreneur and BioLongevity Labs co-founder Josh Felber joins Ryan Alford and Chris Hansen for a wide-ranging conversation about peptides, GLP-1 medications, recovery, and health optimization. Josh explains why weight loss is only part of the GLP-1 conversation and why protecting lean muscle requires greater attention to nutrition and resistance training.

The discussion explores emerging research involving SLU-PP-332, BPC-157, TB-500, SS-31, bioregulators, and NAD+ therapy. Ryan and Chris also ask Josh which daily practices still produce meaningful results when expensive supplements and experimental compounds are removed from the equation.

Listeners will hear perspectives on the opportunities, limitations, and unanswered questions surrounding the growing peptide and longevity industries.

TOPICS COVERED

Josh Felber’s path into health and longevity

The rise of research peptides

GLP-1 medications and muscle preservation

Exercise, protein, and sustainable weight loss

Experimental research involving SLU-PP-332

Peptides associated with injury-recovery research

Cellular health, metabolism, and SS-31

NAD+ IV therapy